9BG0
Tri-complex of Daraxonrasib (RMC-6236), NRAS WT, and CypA
This is a non-PDB format compatible entry.
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | CLSI BEAMLINE 08ID-1 |
| Synchrotron site | CLSI |
| Beamline | 08ID-1 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2024-01-19 |
| Detector | DECTRIS PILATUS 6M |
| Wavelength(s) | 0.97946 |
| Spacegroup name | P 21 21 21 |
| Unit cell lengths | 65.480, 81.710, 127.880 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 37.790 - 1.640 |
| R-factor | 0.208 |
| Rwork | 0.206 |
| R-free | 0.23630 |
| Structure solution method | MOLECULAR REPLACEMENT |
| RMSD bond length | 0.006 |
| RMSD bond angle | 0.872 |
| Data reduction software | HKL-2000 |
| Data scaling software | HKL-2000 |
| Phasing software | PHASER |
| Refinement software | PHENIX (1.20.1_4487) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 37.790 | 1.699 |
| High resolution limit [Å] | 1.640 | 1.640 |
| Rmerge | 0.145 | 2.991 |
| Rmeas | 0.151 | 3.102 |
| Rpim | 0.041 | 0.820 |
| Number of reflections | 84668 | 8332 |
| <I/σ(I)> | 12.28 | |
| Completeness [%] | 100.0 | 99.95 |
| Redundancy | 13.5 | 14.1 |
| CC(1/2) | 0.999 | 0.354 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 8 | 291 | 29% PEG4000, 0.1 M Tris, pH 8 |






